Yuhan Corporation: all 172 studies

Page 1 of 2. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination TherapyNot yet recruitingNCT07816198Phase 3
• A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236BNot yet recruitingNCT07730567Phase 1
• A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male VolunteersNot yet recruitingNCT07722871Phase 1
• A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy AdultsNot yet recruitingNCT07717775Phase 1
• A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult SubjectsNot yet recruitingNCT07717749Phase 1
• A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male VolunteersNot yet recruitingNCT07715305Phase 1
• A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy AdultsNot yet recruitingNCT07618845Phase 1
• A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231CNot yet recruitingNCT07590167Phase 1
• Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the KneeNot yet recruitingNCT07550231Phase 2
• A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232Not yet recruitingNCT07538466Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy AdultsNot yet recruitingNCT07521241Phase 1
• A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult SubjectsNot yet recruitingNCT07476157Phase 1
• A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male SubjectsRecruitingNCT07444385Phase 1
• Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-AntihistaminesRecruitingNCT07415551Phase 2
• A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy AdultsNot yet recruitingNCT07385248Phase 1
• Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'RecruitingNCT07385235Phase 1
• Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322Not yet recruitingNCT07312799Phase 1
• A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231CNot yet recruitingNCT07312773Phase 1
• A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117ANot yet recruitingNCT07152873Phase 1
• The Food Effect on PK Characteristics and Safety Profiles of PA-111Not yet recruitingNCT06976489Phase 1
• Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid TumorsRecruitingNCT06975410Phase 1/2
• A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111ARecruitingNCT06932705Phase 1
• A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120ANot yet recruitingNCT06916130Phase 1
• A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284RecruitingNCT06884098Phase 1
• Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral NutritionRecruitingNCT06625957Phase 3
• A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946RecruitingNCT06616766Phase 1/2
• A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227BRecruitingNCT06441630Phase 3
• A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid TumorRecruitingNCT06365840Phase 2
• Phase III Study to Evaluate the Efficacy and Safety of AD-209RecruitingNCT06348576Phase 3
• An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and ASRecruitingNCT05835518
• Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid TumorRecruitingNCT05523947Phase 1/2
• A Study to Evaluate the Efficacy and Safety of AD-218RecruitingNCT05400317Phase 3
• A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard TherapyRecruitingNCT05276310Phase 1
• Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)CompletedNCT04248829Phase 3Results posted
• Bioequivalence Study of Letrozole 2.5 mg TabletsCompletedNCT01084499Not applicableResults posted
• Bioequivalence Study Between YHP2508C and YHR2603 in Healthy SubjectsCompletedNCT07584304Phase 1
• A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult VolunteersCompletedNCT07495514Phase 1
• Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy VolunteersCompletedNCT07470125Phase 1
• Bioequivalence Study Between YHP2406 and YHR2501 in Healthy SubjectsCompletedNCT07265167Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute BronchitisCompletedNCT07111468Phase 3
• A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male VolunteersCompletedNCT07103278Phase 1
• Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy SubjectsCompletedNCT06926387Phase 1
• Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy SubjectsCompletedNCT06920719Phase 1
• The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'CompletedNCT06902818Phase 1
• A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227BCompletedNCT06884085Phase 1
• A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282CompletedNCT06858865Phase 1
• Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy VolunteersCompletedNCT06775522Phase 1
• A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282CompletedNCT06747936Phase 3
• Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral NutritionCompletedNCT06625931Phase 3
• Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy VolunteersCompletedNCT06623526Phase 1
• Bioequivalence Study Between YHP2305 and YHR2404 in Healthy VolunteersCompletedNCT06613139Phase 1
• A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male ParticipantsActive, not recruitingNCT06517914Phase 1
• Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022CompletedNCT06448962Phase 3
• Bioequivalence Study Between YHP2205 and YHR2401 in Healthy VolunteersCompletedNCT06359626Phase 1
• Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and HypercholesterolemiaCompletedNCT06293261
• A Study to Evaluate the Efficacy and Safety of AD-224CompletedNCT06291207Phase 3
• Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential HypertensionActive, not recruitingNCT06282549
• Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR MutationActive, not recruitingNCT06247280
• A Study to Evaluate the Efficacy and Safety of AD-223CompletedNCT06052748Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive DiseaseCompletedNCT06046196Phase 4
• Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential HypertensionActive, not recruitingNCT06041529Phase 4
• A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121CompletedNCT06025773Phase 1
• A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic DiseasesCompletedNCT05960708Phase 1
• Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLCCompletedNCT05862194
• A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery DiseaseCompletedNCT05730621Phase 4
• A Study to Assess the Safety and Pharmacokinetics of AD-104-ACompletedNCT05703282Phase 1
• A Study to Evaluate the Efficacy and Safety of AD-209CompletedNCT05631990Phase 2
• A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic PainCompletedNCT05624853Phase 4
• Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy WomenStatus unknownNCT05587283Phase 1
• A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic DiseasesCompletedNCT05564221Phase 1
• BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy SubjectsCompletedNCT05418803Phase 1
• A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221BCompletedNCT05202405Phase 1
• Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.CompletedNCT05162274Phase 1
• A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221ACompletedNCT05131997Phase 3
• A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091CompletedNCT05128591Phase 1
• A Study to Compare PK, PD and Safety of the AD-214 and AD-2141CompletedNCT05062876Phase 1
• A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic DiseasesCompletedNCT05061524Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy SubjectsCompletedNCT05012436Phase 1
• Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral NeuropathyCompletedNCT04846673Phase 4
• Early Access Program of Lazertinib in Republic of KoreaApproved for marketingNCT04829422
• A Study to Evaluate the Efficacy and Safety of AD-208CompletedNCT04825561Phase 3
• A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132CompletedNCT04755985Phase 1
• A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131CompletedNCT04690868Phase 1
• A Study to Compare PK, PD and Safety of the AD-214-02 and RabeprazoleCompletedNCT04622358Phase 1
• Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102CompletedNCT04600284Phase 1
• A Study to Compare PK, PD and Safety of the AD-214 10/600mg and RabeprazoleCompletedNCT04494243Phase 1
• A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal TypeActive, not recruitingNCT04414163Phase 2
• Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112CompletedNCT04375865Phase 1
• Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mgCompletedNCT04316065Phase 1
• A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory LymphomasCompletedNCT04306224Phase 1
• Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy VolunteersCompletedNCT04225052Phase 1
• Determining the Optimal Dose of AD-209 in Patients With Essential HypertensionCompletedNCT04218552Phase 2
• To Evaluate the Pharmacokinetics and Safety of AD-208CompletedNCT04214808Phase 1
• Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/AmlodipineCompletedNCT04158076Phase 3
• A Study to Evaluate the Efficacy and Safety of AD-203CompletedNCT04066530Phase 3
• Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary SyndromeCompletedNCT04056169Phase 4
• A Study to Compare PK, PD and Safety of the AD-206 and EsomeprazoleCompletedNCT03980756Phase 1
• Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With DyslipidemiaCompletedNCT03951207Phase 4
• Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and TelmisartanCompletedNCT03872232Phase 3
• Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy VolunteersCompletedNCT03824171Phase 1

← Yuhan Corporation overview and focus areas